Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis

Background. To comprehensively assess the efficacy and safety of whole-brain radiotherapy (WBRT) combined with gefitinib/erlotinib for treatment of brain metastases (BM) from non-small-cell lung cancer (NSCLC). Methods. Databases including PubMed, EMBASE.com, Web of Science, and Cochrane Library wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Mao-hua, Sun, Hong-tao, Xu, Ji-guang, Yang, Gang, Huo, Lei-ming, Zhang, Pan, Tian, Jin-hui, Yang, Ke-hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783530/
https://www.ncbi.nlm.nih.gov/pubmed/27006948
http://dx.doi.org/10.1155/2016/5807346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783530/
https://www.ncbi.nlm.nih.gov/pubmed/27006948
http://dx.doi.org/10.1155/2016/5807346

Ejemplares similares